Clinical trial
A Postmarketing Surveillance Study Evaluating the Safety and Local Tolerance of PREVENAR in Indian Children
NCT00488800 is registered in ClinicalTrials.gov with Wyeth is now a wholly owned subsidiary of Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Postmarketing Surveillance Study Evaluating the Safety and Local Tolerance of PREVENAR in Indian Children
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2006
- Completion date
- January 31, 2007
- Enrollment
- 1,000
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.